MGF — Mechano Growth Factor Research

Last updated: June 2026

MGF (Mechano Growth Factor) is an IGF-1 splice variant with a unique 24-amino-acid E-domain. In animal models, MGF mRNA is upregulated in skeletal muscle after mechanical stress. In cell assays, MGF has been studied for IGF-1R binding and E-domain satellite cell activity. The following is a review of cell and animal model findings on MGF structure, receptor binding, and tissue expression.

Next Level Pharm is a US supplier of research-grade peptides. MGF is available with a full COA verified by HPLC and mass spec on every lot. Purity is ≥99% per batch. The average purity across the last 100 batches is 99.4%.

MGF was first identified in rodent skeletal muscle tissue after mechanical loading studies. The IGF1 gene produces multiple splice variants depending on the tissue and stimulus. MGF is one of the splice variants. It differs from the systemic IGF-1 Ea isoform in its C-terminal E-domain sequence. This E-domain gives MGF distinct cell activity in vitro.

Key Takeaways

MGF Is a Splice Variant of the IGF1 Gene: MGF forms when the IGF1 gene splices to use exon 4. The result is a 70-amino-acid precursor with a unique 24-amino-acid E-domain at the C-terminus.
The E-Domain Is Not Found in Standard IGF-1: The 24-amino-acid C-terminal E-domain of MGF has a different sequence than the Ea domain of systemic IGF-1. In cell assays, the E-domain alone has been studied for satellite cell migration and proliferation distinct from IGF-1R signaling.
MGF Binds the IGF-1 Receptor: MGF shares the IGF-1 binding domain and binds IGF-1R in cell assays. IGF-1R binding triggers PI3K-Akt and MAPK-ERK signaling paths in myocyte cell lines.
MGF Has a Short Plasma Half-Life: In animal models, native MGF is cleared from plasma in under 5 minutes. This short t½ limits its use in animal studies. PEGylation is studied as a way to extend MGF t½ to hours.
All Data Are From Cell and Animal Models: MGF is not FDA-approved. All findings cited are from cell assays or rodent model studies.

The MGF E-domain peptide (sometimes called MGF-Ct24E) has been studied as a separate research compound from full-length MGF. In cell assays, MGF-Ct24E has been studied for satellite cell migration behavior that is distinct from IGF-1R-driven effects. These are in-vitro findings.

What Is the Structure of MGF?

MGF is a 70-amino-acid peptide (in its processed mature form) produced by alternative splicing of the IGF1 gene. The IGF1 gene has 6 exons. When exon 4 is included, the result is a frameshift that creates a unique 24-amino-acid E-domain at the C-terminus.

The N-terminal region of MGF (amino acids 1-49) is identical to IGF-1. This region contains the IGF-1R binding domain. The C-terminal E-domain (amino acids 50-70 in the MGF sequence) is unique to MGF and differs from the Ea domain of systemic IGF-1.

According to NCBI (2019), MGF has been studied as an IGF-1 splice variant with a distinct C-terminal E-domain. The data showed that the E-domain peptide has cell activity separate from IGF-1R binding in myocyte assays. These are in-vitro findings.

What Does the MGF E-Domain Do in Cell Assays?

The MGF E-domain peptide (24 amino acids) has been studied separately from full-length MGF in cell assays. In satellite cell assays, the E-domain alone has been found to drive satellite cell migration without binding IGF-1R. This suggests that MGF’s E-domain acts through a distinct, yet unidentified receptor or pathway.

In C2C12 myoblast cell lines, the E-domain has been studied for its effect on cell division markers. In primary satellite cells from rodent tissue, the E-domain has been studied for cell migration rates. These are in-vitro findings from cell line and primary cell studies.

According to NCBI (2015), the MGF E-domain peptide alone has been studied for satellite cell activity in cell assays. The data showed satellite cell migration responses to the E-domain that were not blocked by IGF-1R inhibitors. These are in-vitro findings.

How Is MGF Expression Regulated in Animal Models?

In rodent models, MGF mRNA expression in skeletal muscle is low at baseline. After mechanical loading or damage, MGF mRNA levels rise rapidly (within hours). This is a local, tissue-level response distinct from systemic IGF-1 secretion by the liver.

The mechanical stimulus that drives MGF expression has been studied using stretch assays in isolated muscle preparations and in-vivo loading models. In aging rodent models, the MGF mRNA response to mechanical stress is reduced compared with young adult animals. This is a rodent finding and has not been confirmed in human tissue.

According to doi.org (2003), MGF mRNA was found to increase rapidly in rodent skeletal muscle after mechanical stimulation. The data showed a different time course for MGF vs Ea-IGF-1 mRNA expression. These are animal model findings from rodent tissue studies.

Feature	MGF	IGF-1 (Ea isoform)
Gene	IGF1 (alternative splice)	IGF1 (Ea exon)
Length (mature)	~70 amino acids	~70 amino acids
E-domain	Unique 24-AA sequence	Standard Ea domain
IGF-1R binding	Yes (same N-terminal domain)	Yes
Plasma t½	Under 5 minutes (rodent)	~15 minutes (systemic)
Primary source	Skeletal muscle (local)	Liver (systemic)

MGF is available as a COA-verified research peptide. Every lot is verified by HPLC and mass spec.

How Is MGF Different from PEG-MGF?

Native MGF has a plasma half-life of under 5 minutes in rodent models due to rapid enzyme cleavage and renal filtration. PEG-MGF is a PEGylated form of MGF with a polyethylene glycol (PEG) chain added at the C-terminus. The PEG chain raises the hydrodynamic size of the peptide and slows renal filtration.

In rodent PK studies, PEG-MGF has been found at detectable plasma levels for 4-6 hours vs under 5 minutes for native MGF. The trade-off is that the PEG chain at the C-terminus may reduce E-domain activity in cell assays. Researchers select between native MGF and PEG-MGF based on study duration requirements.

What Downstream Cell Signals Does IGF-1R Binding Trigger?

IGF-1R (the IGF-1 receptor) is a transmembrane tyrosine kinase receptor. When MGF binds IGF-1R in cell assays, the receptor auto-phosphorylates. This triggers two main downstream paths: PI3K-Akt and MAPK-ERK.

The PI3K-Akt path is linked to cell survival and protein synthesis in myocyte cell lines. The MAPK-ERK path is linked to cell cycle entry and cell division markers. Both paths have been studied in C2C12 myoblast cells treated with MGF in vitro. These are cell assay findings and are not clinical data.

Frequently Asked Questions

What Is MGF?

MGF (Mechano Growth Factor) is an alternative splice variant of the IGF1 gene. It produces a unique 24-amino-acid C-terminal E-domain not found in standard IGF-1. In animal models, MGF mRNA is upregulated in skeletal muscle after mechanical stress. In cell assays, MGF has been studied for both IGF-1R binding and E-domain-specific satellite cell activity. MGF is not FDA-approved.

What Is the E-Domain of MGF?

The E-domain of MGF is a 24-amino-acid C-terminal peptide unique to the MGF splice variant. It is produced by a frameshift in exon 4 of the IGF1 gene. In cell assays, the E-domain alone (MGF-Ct24E) has been studied for satellite cell migration activity independent of IGF-1R binding. These are in-vitro findings.

Does MGF Bind IGF-1R?

Yes. MGF retains the IGF-1 binding domain in its N-terminal region (amino acids 1-49). This domain binds IGF-1R in cell assays. IGF-1R binding by MGF triggers the same downstream PI3K-Akt and MAPK-ERK paths as IGF-1. The E-domain of MGF also shows distinct cell activity through a separate, yet-to-be-confirmed receptor.

How Is MGF Different from IGF-1?

MGF and IGF-1 are both coded by the IGF1 gene but use different exon splices. They share the same N-terminal IGF-1R binding domain. MGF has a unique 24-amino-acid E-domain at the C-terminus while IGF-1 Ea has the standard Ea domain. MGF is expressed locally in skeletal muscle after mechanical stress. IGF-1 Ea is expressed mainly in the liver and secreted systemically.

What Is the Half-Life of MGF in Animal Models?

In rodent plasma, native MGF is cleared in under 5 minutes. This is due to rapid enzyme cleavage by peptidases and small-peptide renal filtration. This short t½ limits the use of native MGF in animal dosing protocols. PEGylated forms (PEG-MGF) are studied as alternatives with a 4-6 hour t½ in rodent models.

What Is Satellite Cell Activation in MGF Research?

Satellite cells are adult stem cells in skeletal muscle tissue marked by the Pax7 transcription factor in rodent models. In cell assays, satellite cell activation refers to the transition from a quiescent state to a dividing state. The MGF E-domain has been studied for its role in satellite cell migration and activation in vitro. These are cell model findings.

How Is MGF Purity Confirmed?

Each lot of MGF at Next Level Pharm is tested by HPLC and mass spec. HPLC confirms purity (≥99%). Mass spec confirms the molecular weight and sequence identity of the MGF peptide. Researchers should confirm the lot number on the COA matches the vial before any study use.

What Cell Lines Are Used in MGF Research?

MGF has been studied in C2C12 myoblast cell lines (a standard mouse muscle cell model). It has also been studied in primary satellite cells from rodent skeletal muscle and in L6 myocyte cell lines. These are standard in-vitro models. All findings from these cell lines are in-vitro data and are not clinical results.

Is MGF FDA-Approved?

No. MGF is not FDA-approved. It is a research compound used in cell and animal model studies only. All data in this overview are from in-vitro assays and rodent model studies. MGF is not approved for any clinical or therapeutic use.

Summary

MGF (Mechano Growth Factor) is an IGF-1 splice variant with a unique 24-amino-acid E-domain. It binds IGF-1R and has E-domain-specific satellite cell activity in cell assays. In rodent models, MGF mRNA is upregulated in skeletal muscle after mechanical stress. Native MGF has a short plasma t½ (under 5 minutes) due to rapid enzyme cleavage.

All findings are from cell and animal research models. MGF is not FDA-approved. For research purposes only.

What Should You Do Next?

Researchers sourcing MGF should confirm HPLC purity and mass spec identity from the COA for each lot. The molecular weight on the COA should match the expected 70-amino-acid mature MGF sequence. Lot numbers should match the COA on file before any study use.

Shop research peptides at Next Level Pharm. COA-verified on every batch.

About the Author

Next Level Pharm Research Team

Alex M covers peer-reviewed findings in peptide science for Next Level Pharm, a US-based supplier of research-grade peptides verified to ≥99% purity via HPLC and mass spectrometry on every batch.

Disclaimer: The information provided on this page is for educational and research purposes only. Next Level Pharm products are intended for laboratory research use only. They are not intended for human consumption, diagnostic, therapeutic, or medicinal purposes. This content does not constitute medical advice. Always consult a licensed healthcare professional before making any health-related decisions.

MGF Research: Mechano Growth Factor Mechanism and Study Findings